WeTrials
Recruiting

A Randomized, Phase III Trial of Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions in Older Women With Early-Stage Breast Cancer (POWER II)

What is this study?

This study is looking at older women with early-stage breast cancer to see if taking hormone-blocking medication before surgery can help doctors make better decisions about radiation therapy. We want to find ways to make treatments as gentle and effective as possible for you.

Who can participate?

You may be able to join if you are a woman aged 65 or older, diagnosed with a common type of early-stage breast cancer called ER-positive, and are planning to have a lumpectomy followed by radiation.

What will happen?

You will be randomly placed into one of two groups. One group will take hormone therapy pills for three months before surgery, while the other group will go straight to standard surgery, and both groups will share their experiences through simple surveys.

Where and when?

This study is currently recruiting participants at medical centers in locations including New Haven, Connecticut, and Charlottesville and Culpeper, Virginia.

Key Points
  • 1Testing if hormone pills before surgery help plan radiation better
  • 2Open to women aged 65 and older with specific early-stage breast cancer
  • 3Involves regular surveys about how you feel during treatment

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Breast Cancer Female

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.